Cargando…

Peripheral Inflammatory Cytokine Signature Mirrors Motor Deficits in Mucolipidosis IV

Background: Mucolipidosis IV (MLIV) is an autosomal recessive pediatric disease that leads to motor and cognitive deficits and loss of vision. It is caused by a loss of function of the lysosomal channel transient receptor potential mucolipin-1 and is associated with an early pro-inflammatory brain p...

Descripción completa

Detalles Bibliográficos
Autores principales: Misko, Albert L., Weinstock, Laura D., Sankar, Sitara B., Furness, Amanda, Grishchuk, Yulia, Wood, Levi B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834097/
https://www.ncbi.nlm.nih.gov/pubmed/35159355
http://dx.doi.org/10.3390/cells11030546
_version_ 1784649098430775296
author Misko, Albert L.
Weinstock, Laura D.
Sankar, Sitara B.
Furness, Amanda
Grishchuk, Yulia
Wood, Levi B.
author_facet Misko, Albert L.
Weinstock, Laura D.
Sankar, Sitara B.
Furness, Amanda
Grishchuk, Yulia
Wood, Levi B.
author_sort Misko, Albert L.
collection PubMed
description Background: Mucolipidosis IV (MLIV) is an autosomal recessive pediatric disease that leads to motor and cognitive deficits and loss of vision. It is caused by a loss of function of the lysosomal channel transient receptor potential mucolipin-1 and is associated with an early pro-inflammatory brain phenotype, including increased cytokine expression. The goal of the current study was to determine whether blood cytokines are linked to motor dysfunction in patients with MLIV and reflect brain inflammatory changes observed in an MLIV mouse model. Methods: To determine the relationship between blood cytokines and motor function, we collected plasma from MLIV patients and parental controls concomitantly with assessment of motor function using the Brief Assessment of Motor Function and Modified Ashworth scales. We then compared these profiles with cytokine profiles in brain and plasma samples collected from the Mcoln1(−/−) mouse model of MLIV. Results: We found that MLIV patients had prominently increased cytokine levels compared to familial controls and identified profiles of cytokines correlated with motor dysfunction, including IFN-γ, IFN-α2, and IP-10. We found that IP-10 was a key differentiating factor separating MLIV cases from controls based on data from human plasma, mouse plasma, and mouse brain. Conclusions: Our data indicate that MLIV is characterized by increased blood cytokines, which are strongly related to underlying neurological and functional deficits in MLIV patients. Moreover, our data identify the interferon pro-inflammatory axis in both human and mouse signatures, suggesting that interferon signaling is an important aspect of MLIV pathology.
format Online
Article
Text
id pubmed-8834097
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88340972022-02-12 Peripheral Inflammatory Cytokine Signature Mirrors Motor Deficits in Mucolipidosis IV Misko, Albert L. Weinstock, Laura D. Sankar, Sitara B. Furness, Amanda Grishchuk, Yulia Wood, Levi B. Cells Article Background: Mucolipidosis IV (MLIV) is an autosomal recessive pediatric disease that leads to motor and cognitive deficits and loss of vision. It is caused by a loss of function of the lysosomal channel transient receptor potential mucolipin-1 and is associated with an early pro-inflammatory brain phenotype, including increased cytokine expression. The goal of the current study was to determine whether blood cytokines are linked to motor dysfunction in patients with MLIV and reflect brain inflammatory changes observed in an MLIV mouse model. Methods: To determine the relationship between blood cytokines and motor function, we collected plasma from MLIV patients and parental controls concomitantly with assessment of motor function using the Brief Assessment of Motor Function and Modified Ashworth scales. We then compared these profiles with cytokine profiles in brain and plasma samples collected from the Mcoln1(−/−) mouse model of MLIV. Results: We found that MLIV patients had prominently increased cytokine levels compared to familial controls and identified profiles of cytokines correlated with motor dysfunction, including IFN-γ, IFN-α2, and IP-10. We found that IP-10 was a key differentiating factor separating MLIV cases from controls based on data from human plasma, mouse plasma, and mouse brain. Conclusions: Our data indicate that MLIV is characterized by increased blood cytokines, which are strongly related to underlying neurological and functional deficits in MLIV patients. Moreover, our data identify the interferon pro-inflammatory axis in both human and mouse signatures, suggesting that interferon signaling is an important aspect of MLIV pathology. MDPI 2022-02-04 /pmc/articles/PMC8834097/ /pubmed/35159355 http://dx.doi.org/10.3390/cells11030546 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Misko, Albert L.
Weinstock, Laura D.
Sankar, Sitara B.
Furness, Amanda
Grishchuk, Yulia
Wood, Levi B.
Peripheral Inflammatory Cytokine Signature Mirrors Motor Deficits in Mucolipidosis IV
title Peripheral Inflammatory Cytokine Signature Mirrors Motor Deficits in Mucolipidosis IV
title_full Peripheral Inflammatory Cytokine Signature Mirrors Motor Deficits in Mucolipidosis IV
title_fullStr Peripheral Inflammatory Cytokine Signature Mirrors Motor Deficits in Mucolipidosis IV
title_full_unstemmed Peripheral Inflammatory Cytokine Signature Mirrors Motor Deficits in Mucolipidosis IV
title_short Peripheral Inflammatory Cytokine Signature Mirrors Motor Deficits in Mucolipidosis IV
title_sort peripheral inflammatory cytokine signature mirrors motor deficits in mucolipidosis iv
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834097/
https://www.ncbi.nlm.nih.gov/pubmed/35159355
http://dx.doi.org/10.3390/cells11030546
work_keys_str_mv AT miskoalbertl peripheralinflammatorycytokinesignaturemirrorsmotordeficitsinmucolipidosisiv
AT weinstocklaurad peripheralinflammatorycytokinesignaturemirrorsmotordeficitsinmucolipidosisiv
AT sankarsitarab peripheralinflammatorycytokinesignaturemirrorsmotordeficitsinmucolipidosisiv
AT furnessamanda peripheralinflammatorycytokinesignaturemirrorsmotordeficitsinmucolipidosisiv
AT grishchukyulia peripheralinflammatorycytokinesignaturemirrorsmotordeficitsinmucolipidosisiv
AT woodlevib peripheralinflammatorycytokinesignaturemirrorsmotordeficitsinmucolipidosisiv